
Sign up to save your podcasts
Or


Professor David Putrino is a physiotherapist with a PhD in Neuroscience. He is currently the Director of Rehabilitation Innovation for the Mount Sinai Health System, and a Professor in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai. Professor Putrino recently opened the Mount Sinai Cohen Center for Recovery from Complex Chronic Illness in New York also known as (CoRE) and serves as CoRE’s Family Director and is also a member of PolyBio’s Long COVID Research Consortium.
Today's episode is the second in a two part series looking at research into potential treatments for Long COVID.
REFERENCES
1 Polybio Article - A clinical trial of repurposed HIV antivirals in Long COVID
2 Patterson BK, Yogendra R, Guevara-Coto J, Mora-Rodriguez RA, Osgood E, Bream J, Parikh P, Kreimer M, Jeffers D, Rutland C, Kaplan G. Case series: maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC). Frontiers in Medicine. 2023 Feb 8;10:1122529.
3 Polybio Article - Long COVID low-dose rapamycin clinical trial
4 Polybio Article - Lumbrokinase Long COVID & ME/CFS clinical trial
By Kojala Medical4.6
1010 ratings
Professor David Putrino is a physiotherapist with a PhD in Neuroscience. He is currently the Director of Rehabilitation Innovation for the Mount Sinai Health System, and a Professor in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai. Professor Putrino recently opened the Mount Sinai Cohen Center for Recovery from Complex Chronic Illness in New York also known as (CoRE) and serves as CoRE’s Family Director and is also a member of PolyBio’s Long COVID Research Consortium.
Today's episode is the second in a two part series looking at research into potential treatments for Long COVID.
REFERENCES
1 Polybio Article - A clinical trial of repurposed HIV antivirals in Long COVID
2 Patterson BK, Yogendra R, Guevara-Coto J, Mora-Rodriguez RA, Osgood E, Bream J, Parikh P, Kreimer M, Jeffers D, Rutland C, Kaplan G. Case series: maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC). Frontiers in Medicine. 2023 Feb 8;10:1122529.
3 Polybio Article - Long COVID low-dose rapamycin clinical trial
4 Polybio Article - Lumbrokinase Long COVID & ME/CFS clinical trial

9,279 Listeners

71 Listeners

34 Listeners

38 Listeners

2 Listeners